Orthovision supplies, reagents, and maintenance

Ended Awarded Last action

Contract number
HT941024F0115
Awardee
Awarding agency
Obligated
$317,627

Award facts

Contract value 40% obligated
  • $317,626.96 Current, with exercised options
  • $794,067.40 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 $158,813
Other Administrative Action P00004 · Clinical diagnostics reagents and supplies $0
Exercise an Option P00003 · Orthopedics clinical diagnostics reagents $0
Other Administrative Action P00002 · Ortho clinical diagnostics reagents $0
Other Administrative Action P00001 · Blood bank testing analyzer supplies $158,813
Original award $0

About this award

Quidelortho Sales Company, LLC, a San Diego-based medical diagnostic equipment distributor and HUBZone joint venture, has been awarded a delivery order valued at $794,067.40 by the Defense Health Agency for orthovision supplies, reagents, and clinical diagnostic supplies. The contract, effective September 30, 2024, with an ultimate completion date of September 30, 2029, operates under firm fixed-price pricing without a set-aside designation and is performed at a facility in Raritan, New Jersey. This delivery order is a child contract issued under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) master schedule, which establishes pricing and terms for laboratory diagnostic equipment and related consumables across federal agencies.

Quidelortho brings substantial federal healthcare contracting experience to this award, having established itself as a key supplier to the Department of Defense, Department of Veterans Affairs, and Indian Health Service through multiple indefinite delivery contracts and blanket purchase agreements. The company's largest existing contract is a $4.281 million blanket purchase agreement with the Indian Health Service, while the Defense Health Agency maintains two significant indefinite delivery contracts totaling approximately $4.326 million for analyzer leases and chemistry support services. This delivery order aligns with the Defense Health Agency's requirements for clinical laboratory diagnostic solutions at military treatment facilities and represents continued expansion of Quidelortho's role as a specialized distributor of blood bank analyzers, immunohematology testing systems, chemistry analyzers, and related laboratory reagents and consumables across the federal healthcare ecosystem.

Quick answers

Who was awarded contract HT941024F0115?

HT941024F0115 was awarded to Quidelortho Sales Company, LLC by Defense Health Agency (Department of Defense) on September 30, 2024.

How much is contract HT941024F0115 worth?

The government has obligated $317,627 on HT941024F0115. Its potential value, with all options, is $794,067.

Is contract HT941024F0115 an order under another contract?

Yes. HT941024F0115 is a delivery order under V797D60637, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract HT941024F0115 competed?

The extent of competition for HT941024F0115 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award